Inovio Pharmaceuticals, Inc. (INO) is a publicly traded Healthcare sector company. As of July 28, 2026, INO trades at $0.97 with a market cap of $79.81M and a P/E ratio of -0.53. INO moved -0.53% today. Year to date, INO is -44.53%; over the trailing twelve months it is -34.35%. Its 52-week range spans $0.96 to $4.44. Analyst consensus is buy with an average price target of $4.25. Rallies surfaces INO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for INO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.97 |
| Market Cap | $79.81M |
| P/E Ratio | -0.53 |
| EPS | $-1.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.44 |
| 52-Week Low | $0.96 |
| Volume | 1.60M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.34K |
| Net Income | $-84.95M |
| Gross Margin | 0.00% |
2 analysts cover INO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.25.